Get the Stockscreener App
48.28
2.51%
1.18
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Axogen Inc stock is traded at $48.28, with a volume of 550.07K.
It is up +2.51% in the last 24 hours and up +5.05% over the past month.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.
See More
Previous Close:
$47.10
Open:
$46.73
24h Volume:
550.07K
Relative Volume:
0.46
Market Cap:
$2.60B
Revenue:
$238.11M
Net Income/Loss:
$-31.45M
P/E Ratio:
-76.22
EPS:
-0.6334
Net Cash Flow:
$7.66M
1W Performance:
-6.20%
1M Performance:
+5.05%
6M Performance:
+65.23%
1Y Performance:
+213.51%
1-Day Range:
$46.29
$48.38
1-Week Range:
$46.29
$51.50
52-Week Range:
$15.27
$52.91
Axogen Inc Stock (AXGN) Company Profile
Name
Axogen Inc
Sector
Industry
Phone
(386) 462-6817
Address
13631 PROGRESS BLVD., ALACHUA, FL
Compare AXGN vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AXGN
Axogen Inc
|
48.28 | 2.50B | 238.11M | -31.45M | 7.66M | -0.6334 |
ABT
Abbott Laboratories
|
108.33 | 197.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
94.17 | 118.14B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
303.13 | 125.70B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
47.80 | 71.55B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
89.90 | 51.78B | 6.30B | 1.07B | 1.09B | 1.8406 |
Axogen Inc Stock (AXGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-19-26 | Initiated | Wells Fargo | Overweight |
| Dec-01-25 | Initiated | Mizuho | Outperform |
| Mar-17-25 | Initiated | Lake Street | Buy |
| Jul-01-24 | Initiated | Raymond James | Outperform |
| Nov-11-22 | Resumed | Jefferies | Buy |
| May-09-22 | Upgrade | Canaccord Genuity | Hold → Buy |
| Mar-11-22 | Resumed | Cantor Fitzgerald | Overweight |
| Oct-23-20 | Initiated | Guggenheim | Buy |
| Jun-16-20 | Resumed | Cantor Fitzgerald | Overweight |
| May-07-20 | Downgrade | Canaccord Genuity | Buy → Hold |
| Apr-02-20 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-07-19 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-12-19 | Initiated | Canaccord Genuity | Buy |
| Mar-02-18 | Reiterated | Lake Street | Buy |
| Jan-05-18 | Resumed | Cantor Fitzgerald | Overweight |
| Nov-30-17 | Initiated | Jefferies | Buy |
| Nov-21-17 | Reiterated | Lake Street | Buy |
| Jul-31-17 | Initiated | Leerink Partners | Outperform |
| Jun-30-17 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-06-17 | Initiated | ROTH Capital | Buy |
| Nov-22-16 | Upgrade | Lake Street | Hold → Buy |
| Nov-07-16 | Reiterated | Wedbush | Outperform |
| Nov-03-16 | Downgrade | Lake Street | Buy → Hold |
| Aug-04-16 | Reiterated | Wedbush | Outperform |
| May-14-14 | Initiated | Dawson James | Buy |
| Oct-31-13 | Reiterated | Ladenburg Thalmann | Buy |
View All
Axogen Inc Stock (AXGN) Latest News
Axogen Inc (AXGN) Shares Surge 8.5% -- What GF Score of 66 Tells Investors - GuruFocus
Price to sales ratio of Axogen, Inc. – BMV:AXGN - TradingView
31,800 Shares in AxoGen, Inc. $AXGN Bought by Edmond DE Rothschild Holding S.A. - MarketBeat
Price to sales ratio of Axogen, Inc. – BIVA:AXGN - TradingView
Taxes of Axogen, Inc. – BMV:AXGN - TradingView
ETFs Investing in Axogen, Inc. Stocks - TradingView
AXGN Stock Price and Chart — BIVA:AXGN - TradingView
Cash per share of Axogen, Inc. – BMV:AXGN - TradingView
Axogen, Inc. Cash Flow – BIVA:AXGN - TradingView
Axogen, Inc. Statistics – BMV:AXGN - TradingView
Lisanti Capital Growth LLC Makes New Investment in AxoGen, Inc. $AXGN - MarketBeat
Tocqueville Asset Management L.P. Takes $8.03 Million Position in AxoGen, Inc. $AXGN - MarketBeat
AxoGen (NASDAQ:AXGN) Sets New 52-Week HighHere's Why - MarketBeat
Axogen stock reaches 52-week high at 50.0 USD - Investing.com
Rice Hall James & Associates LLC Invests $3.41 Million in AxoGen, Inc. $AXGN - MarketBeat
689,833 Shares in AxoGen, Inc. $AXGN Bought by TimesSquare Capital Management LLC - MarketBeat
Axogen director Amy Wendell sells $646k in shares By Investing.com - Investing.com Australia
Axogen director Amy Wendell sells $646k in shares - Investing.com
First Light Asset Management (AXGN) discloses 7.58% Axogen stake for Mathew Arens - Stock Titan
Axogen (AXGN) Q2 2026 Earnings Call Transcript - AOL.com
Axogen EVP Marc Began Executes Stock Option Exercise and Sells Shares Under 10b5-1 Plan - Kalkine Media
Axogen Director Amy McBride-Wendell Executes and Sells 13,353 Shares Under 10b5-1 Plan - Kalkine Media
AxoGen (NASDAQ:AXGN) EVP Marc Began Sells 67,500 Shares of Stock - MarketBeat
AxoGen (NASDAQ:AXGN) Director Sells $646,552.26 in Stock - MarketBeat
Axogen Insider Sold Shares Worth $646,592, According to a Recent SEC Filing - marketscreener.com
Axogen Insider Sold Shares Worth $3,195,788, According to a Recent SEC Filing - marketscreener.com
Q4 2025 AxoGen Inc Earnings Call Transcript - GuruFocus
AxoGen, Inc. $AXGN Shares Sold by Wasatch Advisors LP - MarketBeat
Kathy Johnson Weiler Sells 14,150 Shares of AxoGen (NASDAQ:AXGN) Stock - MarketBeat
Axogen, Inc. SEC Filing (Aug 11, 2026) - Stock Titan
Axogen (AXGN) Is Up 5.4% After Raising 2026 Revenue Outlook Despite Ongoing Losses – Has The Bull Case Changed? - simplywall.st
Axogen Raises Its Revenue Outlook to at Least $279 Million But Does It Deserve An Upgrade? - Smartkarma
Axogen stock hits 52-week high at 47.09 USD By Investing.com - Investing.com South Africa
Axogen stock hits 52-week high at 47.09 USD - Investing.com India
AxoGen (NASDAQ:AXGN) Reaches New 52-Week HighTime to Buy? - MarketBeat
Axogen, Inc. (AXGN) options chain - Yahoo Finance Australia
Assenagon Asset Management S.A. Trims Stock Position in AxoGen, Inc. $AXGN - MarketBeat
MFG Wealth Management Inc. Takes $1.20 Million Position in AxoGen, Inc. $AXGN - MarketBeat
AxoGen Inc (AXGN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Axogen, Inc. (AXGN) director completes 14,150-share stock sale under Rule 10b5-1 plan - Stock Titan
AxoGen Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Axogen (AXGN) Falls 2.28% as Shares Retreat Toward $42 Support ZoneLow Volume Node - Vinanet
Axogen (AXGN) Pulls Back 2.4% to $44.86 as Nerve Repair Stock ConsolidatesLow Beta Factor - vinanet.vn
HC Wainwright Predicts AxoGen's Q1 Earnings (NASDAQ:AXGN) - MarketBeat
Axogen: The Regulatory Moat Is Becoming A Commercial Flywheel (NASDAQ:AXGN) - Seeking Alpha
Axogen Inc (NASDAQ: AXGN) Share Price, AXGN Stock News, AXGN Share Price & Updates - Kalkine
Axogen Inc. (AXGN) Rises 2.08% to $42.21 as Nerve Repair Momentum BuildsAAII Neutral - vinanet.vn
Analysts Have Made A Financial Statement On Axogen, Inc.'s (NASDAQ:AXGN) Second-Quarter Report - simplywall.st
Trace Biosciences Raises Strategic Investment From Axogen - Pulse 2.0
Vanguard Capital Management (AXGN) discloses 4.99% Axogen Inc ownership on Schedule 13G/A - Stock Titan
A Quick Look at Today's Ratings for AxoGen(AXGN.US), With a Forecast Between $53 to $55 - Moomoo
Axogen Inc Stock (AXGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Axogen Inc Stock (AXGN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Began Marc A | EVP & General Counsel |
Aug 10 '26 |
Sale |
47.34 |
67,500 |
3,195,788 |
50,135 |
| Wendell Amy McBride | Director |
Aug 11 '26 |
Option Exercise |
14.85 |
13,353 |
198,292 |
121,329 |
| Wendell Amy McBride | Director |
Aug 11 '26 |
Sale |
48.42 |
13,353 |
646,592 |
107,976 |
0.86%
0.13%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):